Items where authors include "Castellano, D"

Article

van der Heijden, MS, Powles, T, Petrylak, D et al. (22 more authors) (2022) Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial. Nature Communications, 13. 1878. ISSN 2041-1723

Witjes, JA, Babjuk, M, Bellmunt, J et al. (119 more authors) (2020) Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]. European Urology, 78 (1). e48-e50. ISSN 0302-2838

Witjes, JA, Babjuk, M, Bellmunt, J et al. (118 more authors) (2020) EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. European Urology, 77 (2). pp. 223-250. ISSN 0302-2838

Horwich, A, Babjuk, M, Bellmunt, J et al. (118 more authors) (2019) EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Annals of Oncology, 30 (11). pp. 1697-1727. ISSN 0923-7534

Powles, T, Lackner, MR, Oudard, S et al. (18 more authors) (2016) Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology, 34 (14). pp. 1660-1668. ISSN 0732-183X